Based on my research from Finviz and news sources, here are today's top trending stocks and why they're moving: ## Top Trending Stocks Today (May 17, 2026) ### 1. **HCW Biologics (HCWB)** - **+262%** **Why it's moving:** The stock rocketed higher following strong Q1 2026 earnings results. The company reported: - Revenue of $6.5 million (massive improvement from $5,065 in Q1 2025) - Net income of $3.5 million - The revenue gain was attributed to license agreements, including an exclusive worldwide license for HCW11-006 to Trimmune - The stock surged 122.55% in after-hours trading after beating analyst expectations ### 2. **P3 Health Partners (PIII)** - **+42%** **Why it's moving:** The stock surged over 42% after hours, though specific catalyst details weren't immediately available in the search results. This appears to be a significant after-hours move that may be related to company-specific news or developments. ### 3. **Lunai Bioworks (LNAI/RENB)** - **Mixed movement** **Why it's moving:** The stock has seen significant volatility with: - Recent news about a lawsuit filed against "naked" short-sellers of Lunai common stock (May 11-12, 2026) - The company completed a $20 million preferred issuance to acquire CNS delivery and neurotherapeutic IP (May 4, 2026) - Recent reverse stock split announcements (1-for-3 to 1-for-30 ratio approved May 13, 2026) - The stock is trading around $0.26, down 7.01% on May 15 ## Key Market Context These are primarily small-cap biotech/pharmaceutical stocks experiencing high volatility. The movements appear driven by: - **Earnings reports** (HCWB's strong Q1 results) - **Corporate actions** (reverse stock splits, IP acquisitions) - **Legal developments** (short-seller lawsuits) - **After-hours trading volatility** **Note:** These are highly speculative penny stocks with extreme volatility. Always conduct thorough due diligence before making investment decisions.<tool_call> <function=done> <parameter=result>Based on Finviz and news research, here are today's top trending stocks and their catalysts: **1. HCW Biologics (HCWB) - +262%** - Strong Q1 2026 earnings: $6.5M revenue (vs $5,065 in Q1 2025) and $3.5M net income - Revenue driven by exclusive worldwide license agreement for HCW11-006 to Trimmune - Stock surged 122.55% in after-hours trading after beating analyst expectations **2. P3 Health Partners (PIII) - +42%** - Significant after-hours surge, though specific catalyst details weren't immediately available in search results **3. Lunai Bioworks (LNAI/RENB) - Mixed movement** - Recent lawsuit filed against "naked" short-sellers (May 11-12, 2026) - $20M preferred issuance for CNS delivery and neurotherapeutic IP acquisition (May 4, 2026) - Reverse stock split approved (1-for-3 to 1-for-30 ratio, May 13, 2026) - Trading around $0.26, down 7.01% on May 15 **Key Context:** These are primarily small-cap biotech/pharmaceutical stocks experiencing high volatility driven by earnings reports, corporate actions, legal developments, and after-hours trading. Note that these are highly speculative penny stocks with extreme volatility.</parameter> </function> </tool_call>